Molecular markers for colon diagnosis, prognosis and targeted therapy

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Colorectal adenocarcinoma (CRC), the second leading cancer-related death in the United States, remains a global public health issue. Sporadic CRC is considered the result of sequential mucosal changes from normal colonic mucosa to adenocarcinoma. Efforts in understanding the molecular pathways leading to CRC tumorigenesis may lead to identifying novel, individually tailored therapeutic targets for patients. In this review, we focus on well-published prognostic and predictive markers in CRC and examine their role in clinical practice.

Original languageEnglish (US)
Pages (from-to)96-102
Number of pages7
JournalJournal of Surgical Oncology
Volume111
Issue number1
DOIs
StatePublished - Jan 1 2015

Fingerprint

Colon
Adenocarcinoma
Therapeutics
Second Primary Neoplasms
Carcinogenesis
Mucous Membrane
Public Health

Keywords

  • BRAF V600E
  • KRAS
  • MSI
  • PI3K
  • TP53

ASJC Scopus subject areas

  • Surgery
  • Oncology
  • Medicine(all)

Cite this

Molecular markers for colon diagnosis, prognosis and targeted therapy. / Herzig, Daniel; Tsikitis, Vassiliki.

In: Journal of Surgical Oncology, Vol. 111, No. 1, 01.01.2015, p. 96-102.

Research output: Contribution to journalArticle

@article{364de4a0bae14fc995bdac81acddc30a,
title = "Molecular markers for colon diagnosis, prognosis and targeted therapy",
abstract = "Colorectal adenocarcinoma (CRC), the second leading cancer-related death in the United States, remains a global public health issue. Sporadic CRC is considered the result of sequential mucosal changes from normal colonic mucosa to adenocarcinoma. Efforts in understanding the molecular pathways leading to CRC tumorigenesis may lead to identifying novel, individually tailored therapeutic targets for patients. In this review, we focus on well-published prognostic and predictive markers in CRC and examine their role in clinical practice.",
keywords = "BRAF V600E, KRAS, MSI, PI3K, TP53",
author = "Daniel Herzig and Vassiliki Tsikitis",
year = "2015",
month = "1",
day = "1",
doi = "10.1002/jso.23806",
language = "English (US)",
volume = "111",
pages = "96--102",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Molecular markers for colon diagnosis, prognosis and targeted therapy

AU - Herzig, Daniel

AU - Tsikitis, Vassiliki

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Colorectal adenocarcinoma (CRC), the second leading cancer-related death in the United States, remains a global public health issue. Sporadic CRC is considered the result of sequential mucosal changes from normal colonic mucosa to adenocarcinoma. Efforts in understanding the molecular pathways leading to CRC tumorigenesis may lead to identifying novel, individually tailored therapeutic targets for patients. In this review, we focus on well-published prognostic and predictive markers in CRC and examine their role in clinical practice.

AB - Colorectal adenocarcinoma (CRC), the second leading cancer-related death in the United States, remains a global public health issue. Sporadic CRC is considered the result of sequential mucosal changes from normal colonic mucosa to adenocarcinoma. Efforts in understanding the molecular pathways leading to CRC tumorigenesis may lead to identifying novel, individually tailored therapeutic targets for patients. In this review, we focus on well-published prognostic and predictive markers in CRC and examine their role in clinical practice.

KW - BRAF V600E

KW - KRAS

KW - MSI

KW - PI3K

KW - TP53

UR - http://www.scopus.com/inward/record.url?scp=84920133637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920133637&partnerID=8YFLogxK

U2 - 10.1002/jso.23806

DO - 10.1002/jso.23806

M3 - Article

VL - 111

SP - 96

EP - 102

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 1

ER -